Vinay Prasad Md Mph
@vprasadmdmph·195K subscribers·579 videos
Are RCTs needed for new cancer drugs? | Two Oncologists Discuss
Posted
August 7, 2021
Views
776
Likes
23
Comments
2
Engagement
August 7, 2021
776
23
2
3.22%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
33:06Now Playing1. Feasibility of Randomized Controlled Trials for Cancer Drugs Approved by the Food and Drug Administration Based on Single Arm Studies
2. The response rate of alternative treatments for drugs approved on the basis of response rate.
3. Estimation of Study Time Reduction Using Surrogate End Points Rather Than Overall Survival in Oncology Clinical Trials
Vinay Prasad, MD MPH
HemeOnc Doctor & Associate Professor of Epi/ Biostats
Host of Plenary Session Podcast
Twitter @vprasadmdmph
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
